E-LIB Suche - Ergebnisse für: van Deutekom, C.

1

Number of comorbidities is associated with symptom severity..:

Van De Lande, M E ; Van Deutekom, C ; Geelhoed, B...
Europace. 25 (2023) Supplement_1 - p. , 2023

Link: https://doi.org/10.1093/..

2

Clustering of cardiovascular and renal comorbidities and ri..:

Van Deutekom, C ; Geelhoed, B ; Van Munster, B C...
Europace. 25 (2023) Supplement_1 - p. , 2023

Link: https://doi.org/10.1093/..

3

Micronutrient deficiencies and new-onset atrial fibrillatio..:

Al Mubarak, A A ; Grote Beverborg, N ; Zwartkruis, V...
European Heart Journal. 43 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

4

Selenium deficiency is associated with new-onset atrial fib..:

Al-Mubarak, AA ; Grote Beverborg, N ; Zwartkruis, V...
European Journal of Preventive Cardiology. 29 (2022) Supplement_1 - p. , 2022

Link: https://doi.org/10.1093/..

5

Heart rate increase and inappropriate sinus tachycardia aft..:

van Deutekom, C. ; Mulder, B. A. ; Groenveld, H. F....
Netherlands Heart Journal. 30 (2021) 5 - p. 282-288 , 2021

Link: https://doi.org/10.1007/..

6

G.P.87:

Janson, J.A.M. ; Kolfschoten, I.G.M. ; van den Eijnde, R.E.Y....
Neuromuscular Disorders. 24 (2014) 9-10 - p. 820-821 , 2014

Link: https://doi.org/10.1016/..

7

G.P.132:

Mulders, S.A.M. ; Aguilera, B. ; Gonzalez-Barriga, A....
Neuromuscular Disorders. 24 (2014) 9-10 - p. 840 , 2014

Link: https://doi.org/10.1016/..

8

G.P.131:

González-Barriga, A. ; Kranzen, J. ; Croes, H.J.E....
Neuromuscular Disorders. 24 (2014) 9-10 - p. 840 , 2014

Link: https://doi.org/10.1016/..

9

G.P.86:

Kolfschoten, I.G.M. ; Verheul, R.C. ; van Deutekom, J.C.T..
Neuromuscular Disorders. 24 (2014) 9-10 - p. 820 , 2014

Link: https://doi.org/10.1016/..

10

P.11.17 Optimization of preclinical antisense oligonucleoti..:

Kolfschoten, I.G.M. ; Janson, A.A.M. ; den Eijnde, R.E.Y.van...
Neuromuscular Disorders. 23 (2013) 9-10 - p. 803-804 , 2013

Link: https://doi.org/10.1016/..

11

O.12 Peptide-enhanced uptake and bioactivity of antisense o..:

Aguilera, B. ; Mulders, S.A.M. ; Winter, C. Tanganyika-de...
Neuromuscular Disorders. 23 (2013) 9-10 - p. 848 , 2013

Link: https://doi.org/10.1016/..

12

O.11 Development of systemic antisense treatment in dystrop..:

Aartsma-Rus, A.M. ; Tanganyika-de Winter, C.L. ; van Putten, M....
Neuromuscular Disorders. 21 (2011) 9-10 - p. 703 , 2011

Link: https://doi.org/10.1016/..

13

P4.18 Prednisolone treatment does not influence antisense-m..:

Verhaart, I.E.C. ; Heemskerk, J.A. ; de Kimpe, S....
Neuromuscular Disorders. 21 (2011) 9-10 - p. 709 , 2011

Link: https://doi.org/10.1016/..

14

T.P.1.04 Dual exon skipping in myostatin and dystrophin as ..:

Kemaladewi, D.U. ; Hoogaars, W.M.H. ; van Heiningen, S.H....
Neuromuscular Disorders. 19 (2009) 8-9 - p. 577 , 2009

Link: https://doi.org/10.1016/..

15

T.O.4 A phase I/IIa study on antisense compound PRO051 in p..:

Goemans, N.M. ; Buyse, G. ; Tulinius, M....
Neuromuscular Disorders. 19 (2009) 8-9 - p. 659-660 , 2009

Link: https://doi.org/10.1016/..